ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMGastos comerciales, generales y administrativos254.55 M222.71 M215.08 M281.76 M614 K720.17 MInvestigación y desarrollo44.55 M36.4 M38.52 M57.23 M12.63 M144.78 MBeneficio operativo99.76 M125.57 M155.31 M-408.9 M13.87 M-114.14 MTotal de ingresos no operativos7.64 M6.16 M4.89 M7.93 M9.65 M28.62 MGastos por intereses, netos de intereses capitalizados18.64 M18.54 M21.71 M31.84 M28.13 M100.22 MIngresos no operativos, una vez deducidos los gastos por intereses-11 M-12.39 M-16.82 M-23.91 M-18.48 M-71.6 MIngresos/gastos extraordinarios——————Beneficio antes de impuestos-126.76 M108.94 M135.25 M-438.58 M218.94 M24.55 MParticipación en los beneficios——————Impuestos9.9 M13.84 M12.66 M-29.7 M-30.78 M-33.98 MParticipación minoritaria——————Otros ingresos/gastos después de impuestos——————Beneficio neto antes de actividades interrumpidas48.86 M95.1 M122.58 M-408.88 M-3.55 M-194.74 MOperaciones suspendidas-185.52 M-102 K-4 000-15 K-710.78 M-710.9 MBeneficio neto-136.66 M95 M122.58 M-408.89 M-714.33 M-905.64 MAjuste por dilución——————Dividendos de las acciones preferentes——————Beneficio neto diluido atribuible a los accionistas-136.66 M95 M122.58 M-408.89 M-714.33 M-905.64 MBeneficio básico por acción-2.912.082.77-9.24-16.15-20.54Beneficio por acción diluido-2.892.072.77-9.24-16.15-20.55Número medio de acciones ordinarias46.84 M45.78 M44.27 M44.24 M44.62 M178.91 MAcciones diluidas47.09 M45.93 M44.33 M44.24 M44.72 M179.22 MEBITDA1.26 B129.65 M216.98 M107.99 M935.42 M1.39 BEBIT1.04 B61.47 M102.49 M-66.87 M814.93 M912.02 MCosto de los ingresos355.49 M311.23 M349.8 M461.38 M-250.45 M871.96 MOtros costes de producción——————Amortización y depreciación (flujo de caja)220.63 M68.18 M114.49 M174.86 M120.49 M478.02 M
Teleflex Incorporated
Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has annual revenues of $2.4 billion, operations in 40 countries, and more than 15,000 employees. By 2011, the company had substantially realigned to focus on its current business as a medical-device manufacturer, having undergone several years of active acquisitions and divestitures. Teleflex has been associated with Irish corporate tax avoidance tools. Teleflex's chief executive officer is Liam J. Kelly; Kelly is also the company's president and former chief operating officer.